Augmented MYCN Expression Advances the Malignant Phenotype of Human Neuroblastoma Cells: Evidence for Induction of Autocrine Growth Factor Activity

Cancer Research

Volumn 50, Issue 14, 1990, Pages 4411-4416

  Schweigerer, Lothar ^a,b   Breit, Stephen ^a   Wenzel, Achim ^a   Tsunamoto, Kentaro ^a   Schwab, Manfred ^a   Ludwig, Rolf ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CYTOLOGY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; CELL DIVISION; CLONE CELLS; CULTURE MEDIA; DNA, NEOPLASM; EXONS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HUMAN; LIPOPROTEINS, HDL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; ONCOGENES; PHENOTYPE; RESTRICTION MAPPING; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0025347945     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., and Trent, J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (Lond.), 305: 245–248, 1983.
2. Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S., Gilbert, F., and Alt, F. W. Transposition and amplification of oncogene related sequence in human neuroblastomas. Cell, 35: 359–367, 1983.
3. Schwab, M. Amplification of the gene MYCN in human neuroblastoma. Trends Genet., 10: 1–5, 1985.
4. Lee, W. H., Murphree, A. C., and Benedict, W. F. Expression and amplification of the MYCN gene in primary retinoblastoma. Nature (Lond.), 309: 458–460, 1984.
5. Grady-Leopardi, E., Schwab, M., Ablin, A., and Rosenau, W. Expression of MYCN oncogene in neuroblastoma and relationship to clinical outcome. Cancer Res., 46: 3196–3199, 1986.
6. Nisen, P. D., Zimmerman, K. A., Cotter, S. V., Gilbert, F., and Alt, F. W. Enhanced expression of the MYCN gene in Wilms’ tumors. Cancer Res., 46: 6217–6222, 1986.
7. Jacobovits, A., Schwab, M., Bishop, J. M., and Martin, G. R. Expression of MYCN in teratocarcinoma stem cells and mouse embryos. Nature (Lond.), 318: 188–191, 1985.
8. Thiele, C. J., Reynolds, C. P., and Israel, M. A. Decreased expression of MYCN precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (Lond.), 313: 404–406, 1985.
9. Eisenmann, R. N., and Thompson, C. B. Oncogenes with potential nuclear function: myc, myb, and fos. Cancer Surv., 5: 309–327, 1986.
10. Schwab, M., and Bishop, J. M. Sustained expression of the proto-oncogene MYCN rescues rat embryo cells from senescence. Proc. Natl. Acad. Sci. USA, 85: 9585–9589, 1989.
11. Schwab, M., Varmus, H. E., and Bishop, J. M. Human MYCN gene contributes to neoplastic transformation of mammalian cells in culture. Nature (Lond.), 316: 160–162, 1985.
12. Schwab, M., Ellison, J., Busch, M., Rosenau, W., Varmus, H. E., and Bishop, J. M. Enhanced expression of the human gene MYCN consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. USA, 81: 4940–4944, 1984.
13. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S., Wong, K., and Hammond, O. Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 11ll–1116, 1985.
14. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M. Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science (Wash. DC), 224: 1121–1124, 1984.
15. Gospodarowicz, D. Purification of brain and pituitary FGF. Methods En-zymol., 747: 106–119, 1987.
16. Gospodarowicz, D., Lui, G-M., and Gonzalez, R. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix-coated dishes and exposed to defined medium. Cancer Res., 42: 3704–3713, 1982.
17. Ross, R. A., Spengler, B. A., and Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst., 71: 741–749, 1983.
18. Stanton, L. W., Schwab, M., and Bishop, J. M. Nucleotide sequence of the human MYCN gent. Proc. Natl. Acad. Sci. USA, 83: 1772–1776, 1986.
19. Small, M. B., Hay, N., Schwab, M., and Bishop, J. M. Neoplastic transformation by the human gene MYCN. Mol. Cell. Biol., 7: 1638–1645, 1987.
20. Schwab, M., Alitalo, K., Varmus, H. E., Bishop, J. M., and George, D. A cellular oncogene (c-Ki-ros) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumor cells. Nature (Lond.), 303: 497–501, 1983.
21. Schweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes, J. C., and Gospodarowicz, D. Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc. Natl. Acad. Sci. USA, 84: 842–846, 1987.
22. Gospodarowicz, D., Neufeld, G., and Schweigerer, L. Fibroblast growth factor. Mol. Cell. Endocrinol., 46: 187–204, 1986.
23. DeLarco, J. E., and Todaro, G. J. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA, 75: 4001–4005, 1978.
24. Sporn, M. B., and Roberts, A. B. Autocrine growth factors and cancer. Nature (Lond.), 313: 745–747, 1985.
25. Heldin, C. H., and Westermark, B. Growth factors: mechanisms of action and relation to oncogenes. Cell, 37: 9–20, 1984.
26. Gospodarowicz, D. Preparation of extracellular matrices produced by cultured bovine corneal endothelial cells and PF-HR-9 endodermal cells: their use in cell culture. In: D. W. Barnes, D. A. Sirbasku, and G. Sato (eds.), Cell Culture Methods for Molecular and Cell Biology, Vol. 1, pp. 275–293. New York: Alan R. Liss, 1984.
27. Bishop, J. M. The molecular genetics of cancer. Science (Wash. DC), 235: 305–311, 1987.